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Abstract
Background: The NCI-60 is a collection of tumor cell lines derived from a variety of human adult cancer tissue
types and is commonly used for genetic analysis and screening of potential chemotherapeutic agents. We wanted
to understand the contributions of specific mechanisms of genomic instability to the etiology of cancers
represented by the NCI-60.
Results: We screened the NCI-60 for dysregulated homologous recombination by using the gene cluster instability
(GCI) assay we pioneered, and for defects in base excision repair by sensitivity to 5-hydroxymethyl-2’-deoxyuridine
(hmdUrd). We identified subsets of the NCI-60 lines that either displayed the characteristic molecular signature of
GCI or were sensitive to hmdUrd. With the exception of the NCI-H23 lung cancer line, these phenotypes were not
found to overlap. None of the lines examined in either subset exhibited significant changes in the frequency of
sister chromatid exchanges (SCE), neither did any of the lines in either subset exhibit microsatellite instability (MSI)
indicative of defects in DNA mismatch repair.
Conclusions: Gene cluster instability, sensitivity to hmdUrd and sister chromatid exchange are mechanistically
distinct phenomena. Genomic instability in the NCI-60 appears to involve only one mechanism of instability for
each individual cell line.
Background
Genomic instability is a fundamental characteristic of
most solid tumors and adult leukemias. The term
encompasses a broad range of defects that arise by a
variety of damaging events and/or mechanistic failures
of individual DNA repair pathways. Whatever its source,
genomic destabilization is believed to begin early in
tumor progression, creating heterogeneity within a
population of cells, and conferring, in concert with
other events, a selective advantage to a given cell which
dominates in proliferation [1,2]. Instability may or may
not continue as the tumor progresses. One means of
genomic destabilization is defective or dysregulated
homologous recombination.
Homologous recombination (HR) is a mechanism for
repairing double-strand breaks (DSBs) during S and G2
phase of the cell cycle. In contrast to non-homologous
end joining (NHEJ), which results in a loss of genetic
material, homologous recombination is considered
error-free repair because it uses the available, identical
sequence from the sister chromatid to repair the DSB.
Although NHEJ is capable of repairing frank DSBs dur-
ing G2/M, HR is preferred, especially for repairing the
DSBs that arise at stalled replication forks, for example
from forks that encounter single strand breaks or cross-
links [3]. Nevertheless, mitotic HR is a complex, varied,
and tightly regulated process, and defects in several of
the components of HR have long been associated with
cancer (reviewed in [4,5]). One study shows overexpres-
sion of several HR-associated genes in patients with
non-small cell lung cancer [6]. Approximately 5% of the
human genome is comprised of large repetitive elements
called low copy repeats (LCRs), also known as segmental
duplications, which possess sufficiently high sequence
identity to cause structural genomic instability via non-
allelic homologous recombination (NAHR) between
regions of identical sequence but differing genomic con-
text, resulting in insertions, deletions, and translocations
([7], reviewed in [8]).
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homologous recombination, whether in cells with defec-
tive/deficient HR capacity, or in response to damage, is
the sister chromatid exchange assay (SCE) that differen-
tially stains sister chromatids, allowing for microscopic
detection of the physical exchange of DNA which
occurs with crossover HR [9]. With the advent of
straightforward techniques, the SCE assay has been in
popular use since the 1970s for the purpose of identify-
ing potential “chromosomal mutagenicity” of chemical
agents [10]. Chemicals that generate cross-linking of
DNA are potent inducers of SCE, since HR is required
to repair the resultant blockage during replication [11].
Conditions and drugs which increase the number of sin-
gle-strand breaks (SSBs) also increase the number of
SCEs, presumably by overburdening the base-excision
repair (BER) pathway such that unrepaired SSBs remain,
become DSBs during replication, and must be repaired
by homologous recombination [9]. Accordingly, HeLa
cells with downregulated XRCC1, a key component in
the base excision repair pathway, show a 1.7-fold
increase in SCEs, and an almost 2-fold increase when
methyl methansulfonate (MMS), a DNA methylating
agent, is added [12]. Likewise, the thymidine analog 5-
hydroxymethyl-2’-deoxyuridine (hmdUrd) at a 1 μM
dose induces sister chromatid exchanges resulting in a
6-fold increase over background in Chinese hamster
ovary (CHO) cells [13], again presumably through either
saturation of BER activity, or through DNA replication
across nicked BER intermediates. Inhibition or defi-
ciency of poly(ADP-ribose) polymerase (PARP-1) also
increases levels of sister chromatid exchange [14].
Essentially, the HR pathway compensates, at least par-
tially, for the defects or inadequacy of the BER response.
PARP inhibitors can induce synthetic lethality in cells
with mutations in BRCA-1 or BRCA-2, which are com-
ponents of the HR pathway [15,16]. Similarly, exposure
to hmdUrd (or the related compound 5-chloro-2’-deox-
yuridine) is synthetically lethal with loss of key BER
components such as XRCC1 [17].
Despite the striking visible result upon staining, sister
chromatid exchange is genetically silent. It represents a
very large scale physical relocation of genetic material
which is the consequence of a crossover recombination
event; but there is no gain or loss of genetic information
between two identical sisters. Presumably, these cross-
overs happen at the submicroscopic level as well. Our
lab has developed an assay which measures non-silent,
NAHR-mediated molecular level changes to genomic
architecture by monitoring the stability of the length of
gene clusters or tandemly repeated segmental duplica-
tions [18]. For this gene cluster instability (GCI) assay,
we use the gene clusters that produce the 45S precursor
transcript to the 18S, 5.8S and 28S ribosomal RNA
molecules. These clusters of tandemly repeated genes
are located on the small arms of the five acrocentric
chromosome pairs, representing a total of approximately
600 copies of the 43kb unit gene [19]. We characterized
the lengths of these rDNA gene clusters from healthy
blood donors and found complete heterozygosity on
each of the five chromosomes, and between the parental
pairs of homologs. We also detected abundant evidence
of both human meiotic [20] and mitotic rearrangement
[18]. We recently used the GCI assay to compare
matched normal tissue to tumor tissue in patients with
lung or colorectal cancer and found that approximately
50% of the tumors show changes in the sizes of the
clusters compared to the normal tissue, as well as evi-
dence of ongoing instability and heterogeneity within
the tumor population indicating that HR has at some
point become dysregulated within the tumor cells [21].
Notably, loss or knockdown of the RecQ homolog
defective in Bloom syndrome (BLM) causes a remark-
able 100x increase in rDNA gene cluster instability rates
along with the well-characterized 10-fold elevation in
rates of sister chromatid exchange in these cells [22],
suggesting elevated HR with crossing-over as the most
likely mechanism [23] for this destabilization. We also
demonstrated that loss of the ataxia-telangiectasia-
mutated (ATM) protein causes a 10x elevation in rDNA
gene cluster instability, even though loss of ATM in the
absence of exogenous DNA damaging agents does not
increase levels of sister chromatid exchange [24-26].
We are interested in the manner by which elevated
and/or dysregulated recombination may be involved in
the etiology of cancer and the development of che-
motherapeutic resistance. We reasoned that elevated
recombination could be caused either by an increase in
recombination initiating lesions as the result of BER
deficiency as seen in XRCC1 mutants, or by alterations
in the downstream biochemistry of recombination caus-
ing an increase crossover vs. non-crossover recombina-
tion as seen in BLM mutants. Accordingly, we screened
the NCI-60 panel of human cancer cell lines for defec-
tive BER by sensitivity to hmdUrd, and for altered
recombination outcomes by the gene cluster instability
assay. Lines exhibiting either phenotype were subse-
quently characterized by sister chromatid exchange in
order to cross-compare three potential mitotic recombi-
nation indicators.
Results and Discussion
Gene Cluster Instability Survey
For these experiments, we used our gene cluster
instability (GCI) assay to measure dysregulated recombi-
nation by identifying changes in the lengths of riboso-
mal RNA gene (rDNA) clusters. High molecular weight
genomic DNA was digested with EcoRV (New England
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with an average length of 6600 base pairs [27], but does
not have a recognition site within the single rDNA
repeat. The sequence of these repeats is highly con-
served, and thus, an enzyme which does not cut within
a single repeat generally does not cut anywhere in the
cluster of tandemly repeated genes, and the entire clus-
ter can be separated from rest of the genomic DNA by
pulsed-field gel electrophoresis, and identified by South-
ern blotting (Figure 1). We have found that a pulsed-
field gel with a resolution limit of 1MB is the most
informative for tracking changes in cluster length asso-
ciated with GCI. We used this approach to screen the
entire NCI-60 panel of 59 cancer cell lines to identify
those which showed evidence of rDNA cluster instability
(Figure 2). We have previously shown that Bloom syn-
drome cells, which demonstrate a ladder-like banding
pattern, are highly unstable on GCI analysis [18]. It was
on this basis that we identified six lines which demon-
strated laddering indicative of instability as candidates
for further analysis. Three of these were lung cancer
lines (A549, EKVX, and NCI-H23), one was leukemia
(K562), one was breast cancer (T47D), and one was
renal cancer (TK10). According to our previous findings
in tumor versus non-tumor tissue from the same
patient, the frequency of rDNA cluster instability is
about 50%, as indicated by any variation in banding pat-
tern between the normal and malignant tissue at the 1
MB resolution limit [21]. For these experiments, we did
not have access to normal tissue for comparison, and it
is likely that many more than the six lines we chose
show differences from matched normal tissue. Central
nervous system (CNS) cell lines SNB19 and U251 were
derived from the same patient. According to our GCI
results, they demonstrate a similar pattern, with four
common bands, but also deviate from one another with
a total of five bands that are not shared, indicating that
the rDNA has continued to undergo rearrangement in
culture. NCI/ADR-RES and OVCAR8 are also derived
f r o mt h es a m ep a t i e n t ,b u tN C I / A D R - R E Sh a sa c q u i r e d
adriamycin resistance through escalating challenge with
this drug. These lines share three common bands, but
NCI/ADR-RES appears to have acquired an additional
band in culture. The fact that these two lines demon-
strated so little divergence in culture despite the adria-
mycin-mediated DNA damage and acquired resistance
indicates likely mechanistic specificity to the type of
DNA damage that can initiate gene cluster instability. A
third cell line pair, MDA-MB-435 and M14, are also
derived from the same donor. However, these lines have
only a single band below 1MB and it appears stable.
Nine of the NCI-60 lines (HCT-116, HCT-15, KM12,
DU-145, CCRF-CEM, MOLT4, SK-MEL2, IGR-OV1,
SK-OV-3) are known to demonstrate microsatellite
instability indicative of mismatch repair defects [28]. It
is notable that none of the mismatch-repair deficient
lines showed overt evidence of dysregulated recombina-
tion on the initial GCI screen. Although genomic
instability is a hallmark of cancer, it is possible that a
tumor cell may only need a single means of acquiring
instability to confer a selective advantage; and thus mis-
match repair defects and recombination defects are
mutually exclusive within a given tumor cell.
Lines with ongoing GCI: TK-10, K562, T-47D
For the six lines that showed laddering similar to that
seen in Bloom syndrome (Figure 2, circled in red), we
undertook a subclone analysis to determine whether
dysregulated recombination and subsequent instability
was an ongoing process. We duplicated our approach
from the previous Bloom syndrome experiments [18].
We began by isolating colonies derived from a single
cell from the populations that demonstrated gene clus-
ter laddering. In general, the parental population
derived from a single cell usually demonstrates an
initial, well-defined “major banding pattern”. Colonies
from single cells from the cloned parental plate were
grown and GCI analysis was performed. As each clonal
population expands, if the rDNA clusters are comple-
tely stable, the initial cluster lengths found in the par-
ental line will be faithfully transmitted to all
subsequent daughter cells (Figure 3, ‘No GCI’). Alter-
natively, recombination in the expanding population
can generate sub-populations with altered gene cluster
lengths. Since these sub-populations only represent a
fraction of the total population, bands will be reduced
in intensity accordingly. We call these reduced-inten-
sity bands the “minor banding pattern” (Figure 3, ‘Low
GCI’) since the intensity of these bands is non-stoi-
chiometric with respect to the length of the cluster
detected. The amount of this minor-intensity banding
found in any cell population is indicative of the degree
Figure 1 Gene cluster instability experimental strategy. Digestion of genomic DNA with restriction enzymes that do not cut within an
individual gene cluster repeat liberates intact gene clusters from bulk genomic DNA. Panel from [20]. Vertical arrows: putative restriction enzyme
digestion sites. Open rectangles: unit gene cluster repeats.
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requires precise alignment of homologous sequences,
cluster lengths can only change by integer multiples of
the unit repeat length. This constraint upon allowable
gene cluster lengths (Figure 3, dotted lines) means that
very high levels of instability will generate a ladder-like
pattern of bands (Figure 3, ‘High GCI’), consistent with
a recombination-based mechanism. If cluster length
alterations were due to random breakage and rejoining,
a smear would be observed, rather than a ladder [18].
A si nt h ec a s eo fB l o o ms y n d r o m e ,l i n e sw h i c hd e m o n -
strated a laddering pattern in the population some-
times showed non-stoichiometric bands within the
parental population, indicating a high degree of
instability even within the first parental expansion.
We characterize the renal cell cancer TK-10 as having
high GCI (Figure 4). Among the nine subclones there
were a total of nine new minor bands (black arrows), 24
major bands either new or inherited from minor bands
in the parental population (open triangles), and 35 dele-
tions of either major or minor bands from the parental
population (brackets). K562 also showed high GCI (Fig-
ure 4), with three new minor bands (black arrows), six
new major bands (open triangles), and nine major band
deletions (brackets) among the 11 subclones. Interest-
ingly, K562 subclones also showed a stoichiometric lad-
dering pattern of bands which differ by a length of a
single unit repeat (black dots) in the lower range of the
gel. We do not believe these arose by dysregulated
homologous recombination, but rather through site-spe-
cific fragility in the rDNA unit repeat during DNA
Figure 2 Screening the NCI-60 for gene cluster instability (GCI). The presence of a large number of clusters or variable intensity of clusters
suggests instability. Open star: gel resolution limit (1 Mb). Large red rounded rectangles: lines exhibiting gene cluster instability selected for
further analysis. Small rounded rectangles: matching bands consistent with multiple lines derived from the identical patients. Known paired lines:
NCI/ADR-RES & OVCAR-8 (orange), MDA-MB-435 & M14 (blue), SNB-19 & U251 (mauve). Purple arrows: lines sensitive to hmdUrd. Green italicized
names: lines exhibiting microsatellite instability and defects in DNA mismatch repair.
Figure 3 Schematic of subclonal assay to measure GCI rate.A
single cell shows a well-defined pattern of gene cluster lengths
(’Initial Pattern’–thick bands). Allowable, but currently unrepresented
gene cluster lengths are shown as dotted lines. As mitotic division
expands the clonal cell population in the absence of instability,
gene cluster lengths are faithfully preserved (’No GCI’). Alternatively,
instability generates sub-populations within the expanding
population with altered cluster lengths giving rise to lower intensity
‘minor bands’ (’Low GCI’–thin bands indicated by arrows). High
levels of instability generate a ladder-like pattern of minor banding
with individual bands on the ladder differing by integer multiples of
the unit repeat length (’High GCI’). Adapted from [18].
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enon in any of the other subcloned lines, it does some-
times develop in solid tumor and non-tumor tissue [21].
T-47D also appeared unstable on subclone assay (Figure
4), with the appearance of eight new minor bands (black
arrows), five new major bands (open triangles), and one
major band deletion (bracket) across eight subcloned
lines. To contrast with a line exhibiting gene cluster sta-
bility, we also expanded a parental clone and conducted
subclone analysis for MCF7, a breast cancer line that is
well characterized and frequently used for molecular
biology experiments (Figure 4). MCF7 did not demon-
strate laddering on the initial screen (Figure 2) and
showed only two major bands below the 1MB resolution
limit of the gel. MCF7 subclones showed two new
minor bands (black arrows) and no new major bands or
deletions among the eight subclones.
In our previous work with ATM and BLM deficient
cells [Killen, 2009 #1052], we estimated GCI rates in
terms of observed new minor intensity bands per sub-
clone. To a first approximation, wild-type cells had a
GCI rate of 0.1 minor bands per subclone compared to
rates of 1.0 and 10 minor bands per subclone in ATM
and BLM deficient cells respectively. By this measure,
the rates of instability in TK-10, K562, T-47D cells are
more qualitatively similar to the 10x elevated rate in
ATM-deficient cells over wild-type rates, rather than the
more extreme 100x elevated rate in BLM-null cells.
Lines with historical GCI, but currently stable: A549, NCI-
H23, EKVX
Lung cancer cell line A549 does not appear to demon-
strate ongoing rDNA cluster instability (Figure 4). The
major banding pattern from the clonal parental line is
Figure 4 Clonal GCI assays. for each cell line analyzed, TK-10, K562, T-47D, A549, NCI-H23, EKVX and MCF7, clonal populations are on the far
left of each panel with individual subclones derived from single cells in the clonal population on the right. Open star: 1 Mb resolution limit.
Brackets: clusters missing in the subclones, yet present in the clonal population. Open triangles: clusters found in the subclones, yet missing in
the clonal population. Arrows: minor intensity bands from sub-populations arising from mitotic recombination during early subclonal expansion.
Low molecular weight dotted pattern: cluster fragments derived from site-specific fragility in the cluster broken during DNA processing.
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t h ee x c e p t i o no fas i n g l ea d d itional major band in sub-
clone E (Figure 4, open triangle). Lung cancer line NCI-
H23 shows similar results, with the disappearance of a
single band in subclone D (Figure 4). All nine subclones
also appear to have lost two bands that are non-stoi-
chiometric but apparent in the parental line. We attri-
bute this change to the technical details of culturing this
specific line: NCI-H23 does not form single-cell-derived
colonies easily, cells tend to migrate toward one
another, and it may be that the parental population was
not purely derived from expansion of a single cell but
rather became mixed with an independent clone during
the expansion process. We classify the third lung cancer
cell line showing cluster length laddering, EKVX, as hav-
ing low GCI on the basis of subclonal analysis (Figure
4). The parental line shows a single non-stoichiometric
band thought to have arisen during expansion by mito-
tic recombination. Three of the subclonal lines appear
to have inherited this band (subclones C, E, and G),
while the other five (A, B, D, F, and H) did not.
Lack of overlap between GCI and defective mismatch
repair
Nine of the NCI-60 collection of human tumor lines
have defects in mismatch repair with resulting microsa-
tellite instability (Figure 2). The lack of overlap between
lines with gene cluster instability and mismatch repair
defective lines emphasizes the mechanistic differences
between these two aspects of genomic instability.
Sensitivity to hydroxymethyl deoxyuridine (hmdUrd):
HOP-62, NCI-H23, SNB-19, U251, OVCAR-5, NCI/ADR-RES,
786-0
As a functional screen to identify lines exhibiting hyper-
recombination as a result of defective BER biochemistry,
we looked for sensitivity to killing with hmdUrd. The
lines HOP-62, NCI-H23, SNB-19, U251, OVCAR-5,
NCI/ADR-RES and 786-0 showed good sensitivity to
growth inhibition in a single dose growth inhibition
assay (Figure 5). The lines we identified as exhibiting
ongoing gene cluster instability, TK-10, K562 and T-
47D did not show hmdUrd sensitivity, suggesting that
the GCI phenotype of these lines is not related to
defects in base excision repair. It is particularly interest-
ing that the NCI/ADR-RES line is sensitive to hmdUrd,
while the OVCAR-8 line is insensitive. These lines are
derived from the same patient (Figure 2 and [29]), with
the NCI/ADR-RES line selected for growth in progres-
sively higher concentrations of adriamycin [30]. It seems
likely that the OVCAR-8 line became compromised in
BER due to genotoxic damage during adriamycin selec-
tion. It must be noted, however, that we did not directly
measure the incorporation of hmdUrd into the DNA of
treated cell lines. HeLa cells, for example, are known to
be insensitive to hmdUrd due to a failure to incorporate
the molecule into DNA [31]. If similar resistance
mechanisms apply to the NCI-60 cells, there may yet be
BER deficient lines in the NCI-60 collection that are not
identified by the hmdUrd sensitivity screen.
Sister Chromatid Exchange
We performed sister chromatid exchange analysis on
five of the lines which showed initial and/or ongoing
instability (EKVX, NCI-H23, T-47D, TK-10, and K562)
(Figure 6), in order to explore whether elevated levels
of gene cluster instability correlate with elevated levels
of sister chromatid exchange, as is the case for cells
defective in the Bloom syndrome protein BLM [18].
There appears to be some variability between the lines
scored, but in general the number of exchanges is
around 0.125 per chromosome, consistent with values
from wild type fibroblasts (GM00637) that are stable
b yt h eG C Ia s s a y[ 1 8 ] .
Comparison of the two lines showing the greatest dif-
ference in median SCE/chromosome values, TK-10
(0.07) and U251 (0.13) indicates that the difference
between these two lines is statistically significant (P =
0.017, Bonferroni corrected Mann-Whitney test). Never-
theless, we observed that, although the median number
of chromosomes per metaphase in TK-10 is not out of
line with values for the other lines, the chromosomes in
TK-10 tended to be shorter on average than the other
lines, which may limit our ability to score SCEs near the
ends of these shorter chromosomes and artifactually
reduce the TK-10 SCE values. A statistically significant
difference involving pairwise comparisons between the
other lines scored is not seen.
Levels of BLM Protein in Lines With Ongoing GCI
We directly assayed the amount of BLM protein in the
TK-10, T-47D and K562 lines that demonstrate ongoing
GCI (Figure 4), as well as in GCI-stable HeLa and
MCF7 cells, along with a known BLM defective line as a
control (Figure 7). The T-47D line shows greatly
reduced BLM levels relative to the other BLM-contain-
ing cells, although T-47D does not display the charac-
teristic increase in SCE seen in BLM-null lines.
Accordingly, if BLM depletion is the mechanism of
ongoing GCI in T-47D, then elevated GCI would be a
more sensitive readout for BLM depletion than would
be elevated SCE, although the TK-10 and K562 cells
clearly demonstrate that BLM protein level independent
mechanisms for GCI must also exist.
Conclusions
We were surprised to find that gene cluster instability in
the NCI-60 panel of cells did not correspond with
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Page 6 of 10Figure 5 5-hydroxymethyl-2’-deoxyuridine (hmdUrd) sensitivity. Sensitivity screen for a single 10 μM dose. Red text: lines with ongoing
gene cluster instability seen in clonal analysis. Purple text & arrows: lines sensitive to hmdUrd. Green italicized text: lines with microsatellite
instability from defects in DNA mismatch repair.
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observation establishes clear mechanistic differences
between these two processes. Likewise, our observation
that hmdUrd sensitivity in the NCI-60 panel of human
cell lines did not correspond well to elevated SCE activ-
ity previously demonstrated in CHO cells may point to
differences in physiology and metabolism between
humans and rodents.
In summary, of the six lines we identified as defini-
tively demonstrating rDNA GCI instability on initial
screen, only three (T47D, TK10, and K562) continue to
show evidence of ongoing instability at the present time.
The other three appear to have accumulated gene clus-
ter changes in the process of establishing and culturing
the cell lines as the result of transient exogenous influ-
ences, rather than due to an endogenous mechanistic
switch to an elevated gene cluster instability phenotype.
These results are in good accord with our previous
observation in gene cluster unstable human solid tumors
[21] that half of the cases could be attributed to histori-
cal genotoxic damage, while ha l fw e r em o r es u g g e s t i v e
of a biochemical alteration towards an ongoing predis-
position to gene cluster instability.
Methods
Cell Culture
NCI-60 cell lines were acquired frozen from the
National Cancer Institute’s Developmental Therapeutics
Program (DTP), and grown in RPMI-1640 culture med-
ium supplemented with antibiotics and 5% fetal bovine
serum. Cells were maintained in this medium, at 37C, in
5% CO2, in a humidified incubator for the duration of
these experiments.
For subclonal GCI analysis, clonal cultures were initi-
ally generated from the bulk NCI-60 cell populations as
received from the DTP by isolating single cells through
limiting dilution followed by unrestricted expansion. For
Figure 6 Sister chromatid exchange distributions in select NCI-60 lines. Lines are arranged from fewest median SCEs per chromosome (TK-
10) through highest median SCEs per chromosome (U251). Red text: lines with ongoing gene cluster instability seen in clonal analysis. Purple
text: lines sensitive to hmdUrd.
Figure 7 Western blot for BLM protein in select lines. Whole
cell protein lysates from HeLa, BLM-null (Coriell: GM0857), TK-10, T-
47D, K562 and MCF7 cells were blotted. Bands detected with a BLM
antibody and with a b-tubulin antibody as a protein loading control
are indicated.
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the freely expanding clonal cultures were again isolated
by limiting dilution followed by unrestricted expansion.
High Molecular Weight DNA Isolation
Single cell suspensions of 1x10
7 cells/mL in 0.8% low
melting point were drawn into a 1-mL syringe, and
chilled on ice until solidified. High molecular weight
DNA was prepared from the solid-phase agarose cell
suspension by digestion with 1% sarkosyl/500 mM
EDTA/0.5 mg/mL proteinase K solution at 50C for at
least 16 h, after which it was treated with phenylmethyl-
sulfonyl fluoride in 10 mM Tris/1 mM EDTA (TE pH
8.0), extensively rinsed in TE/50% glycerol, and stored at
-20C.
Gene Cluster Instability Analysis
The rRNA gene clusters were analyzed by pulsed-field gel
electrophoresis and Southern blotting essentially as
described [20]. Briefly, approximately 1 μgo fg e n o m i c
DNA in solid phase was digested with EcoRV (New Eng-
land Biolabs) overnight to release intact gene clusters from
bulk genomic DNA. Digested DNA was placed into wells
of a 1% Pulse Field Certified (Bio-Rad) agarose gel consti-
tuted in 0.5x TBE (44.5 mM Tris/44.5 mM boric acid/1.0
mM EDTA pH 8.0) and samples sealed into the wells
using 0.8% low-melting-point agarose. Gels were run
using a CHEF-MAPPER (Bio-Rad) at 14C, with two 6V/
cm field vectors at 120° separation, with a switch time of
from 3” to 90” over 24 hours using a 0.357 ramp factor.
Following electrophoresis, gels were equilibrated to a final
concentration of 0.5% glycerol in water and dried at 65C.
Dried gels were rehydrated and the DNA denatured using
0.4 N NaOH/0.8 mM NaCl, neutralized in 0.5 M Tris pH
8.0/0.8 mM NaCl, then prehybridized at 65C in a hybridi-
zation buffer of 2x SSC (300 mM NaCl/30 mM Na-citrate)
with 7% SDS and 0.5% casein. Gels were probed in fresh
hybridization buffer with an rDNA-specific,
32P-labeled
probe (radiolabeled PCR products amplified from a plas-
mid containing cloned human rDNA sequence using pri-
mers 5’-GGGCTCGAGATTTGGGACGTCAGCTTCTG
and 5’-GGGTCTAGAGTGCTCCCTTCCTCTGTGAG)
at 65C overnight. Southern probing in rehydrated dried
gels maintains quantitative hybridization signal strength
while avoiding documented difficulties involved in trans-
ferring DNA from pulsed-field gels onto membranes
[32,33]. Following two rinses in 2x SSC/1% SDS solution
and two rinses in 0.5x SSC/1% SDS, the gels were imaged
using a PhosphorImager (Molecular Dynamics).
Drug Sensitivity Screen
The in vitro growth inhibition screen of NCI-60 screen
with a single 10 μM dose of 5-hydroxymethyl-2’-deox-
yuridine (hmdUrd) was performed by the National
Cancer Institute’s Developmental Therapeutics Program
according to the methods described online (http://dtp.
nci.nih.gov/branches/btb/ivclsp.html). Briefly, cells are
replica-plated in 96-well microtiter plates. After growth
for 24 hours, time-zero plates are fixed with trichloroa-
cetic acid (TCA) while experimental plates are treated
with drug or left as untreated controls. Experimental
plates are incubated for growth for an additional 48
hours before TCA fixation. Fixed cells are quantified
spectrophotometrically by staining with sulforhodamine
B and growth values are calculated as the mean of
duplicate experiments.
Sister Chromatid Exchange Analysis
Sister chromatid exchanges were prepared using BrdU
and visualized essentially as described [34]. Individual
metaphase spreads were photographed using bright-field
microscopy and a 60x oil immersion objective.
Western Blotting
Protein extracts were prepared using RIPA buffer as
described previously [18]. Following SDS-PAGE, gels
were blotted onto Hybond-ECL nitrocellulose mem-
brane (Amersham Biosciences). Proteins were detected
using rabbit antibodies to BLM (Cell Signaling Technol-
ogies) and b-tubulin (NeoMarkers) with a horseradish
peroxidase conjugated donkey anti-rabbit secondary
antibody (Pierce) and an ECL Plus western blotting
detection system (GE Healthcare).
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